Rheumnow Podcast

Dr. Cush
  • 5,0 (4)
  • MEDICIN
  • UGENTLIGT
Rheumnow Podcast

Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com

  1. ACR24 PsA Topic Panel Advancing Care for Psoriatic Arthritis

    5 TIMER SIDEN

    ACR24 PsA Topic Panel Advancing Care for Psoriatic Arthritis

    Tune in for an engaging discussion at the ACR Annual Meeting! This expert panel will explore the latest breakthroughs and trends in Psoriatic Arthritis(PsA) research and management, providing actionable insights for clinicians and researchers.

    35 min.
  2. ACR 2024 Rheumatology Roundup Featuring Drs. Artie Kavanaugh and Jack Cush

    6 TIMER SIDEN

    ACR 2024 Rheumatology Roundup Featuring Drs. Artie Kavanaugh and Jack Cush

    Highlight presentations from ACR 2024 in Washington, DCCovered abstracts include:- Dr. Kavanaugh1679 Amplified & biomarkers0082 Enthesitis Pathology & IL-231553 TLR 7/8 inhibitors in SLE995 Carbon footprint to injectablesL20 ARTHUR DIANA Automated US1132 VEGA (Combo Rx – see also 2640, 1460, 1393)1745 Statin use in Oral Surveillance - Dr. Cush458 Seronegative RA fateL19 Emapalumab in Stills diseaseACR 2024 updated guidelines on lupus nephritis2580 Ianalumab in SLE2259 Anti-Obesity Meds in RA2657 Mortality with starting/stopping steroids0774  TAPIR study in GCA1697  PMR MODE study

    54 min.
  3. ACR24 SpA Topic Panel Key Discussions on Spondyloarthritis

    1 DAG SIDEN

    ACR24 SpA Topic Panel Key Discussions on Spondyloarthritis

    Join us as we dive into expert insights from the ACR Annual Meeting! This special panel will focus on the latest research and advancements in Spondyloarthritis (SpA), featuring thought leaders in the field.Dr. Marina MagreyClevelandDr. Lihi EderTorontoDr. Sheila ReyesPhillipinesDr. Adela CastroMemphis

    34 min.
  4. ACR24 - RHEUMATOID ARTHRITIS

    2 DAGE SIDEN

    ACR24 - RHEUMATOID ARTHRITIS

    A New ACRCancer Survival in RA"Changing Mindsets about Methotrexate Side Effects"Control RA, Build Stronger BonesCumulative Steroid Use and Cardiovascular EventsDisease Activity in RA-ILDDo TNFis and JAKis Prevent Cancer!?Estimating Inflammation, Damage and Patient DistressFinding the Right Combination Therapy in RAImplantable Vagus Nerve Stimulator for RAIs Frequent Lab Monitoring Necessary?Long Term Follow up from APIPPRAMetabolic Dysregulation and RA Interstitial Lung DiseaseNative Americans with RA Die YoungParaoxonase-1: Possible Biomarker for Progression to RAPred Softly: SteroidsPredicting Flares in Rheumatoid ArthritisRA Roundup: Is LDA Inappropriate? What about Statins for JAKs?RA Treatment Adherence: Is decision making really shared?RA: One JAK to Rule Them All?Sonelokimab in PsA: Phase 2 DataTreat-to-Target Improves Fertility in Women with RATreatment Considerations for RA-ILDTreatment Strategies in RAUse of AI in Hand Ultrasound ScoringVaccine Responses:The DMARD CountsWhat's New in Relapsing Polychondritis?What's The State of Biosimilars?

    1 t. 51 min.
  5. ACR24 - IL-17

    3 DAGE SIDEN

    ACR24 - IL-17

    A New ACRAnti IL-17 on Entheseal Biopsy in PsAaxSpA: Impact of TNF and IL-17 in Patients with Prior TNF ExposureBest Things I Saw Today in PsACycling vs Switching after TNFi Failure in axSpAImprovements in Pain and Fatigue in BimekizumabLong-term Safety Profile of Bimekizumab in axSpA and PsASonelokimab in PsA: Phase 2 DataTreating SpA

    33 min.
  6. ACR24 - JAK_TYK2

    3 DAGE SIDEN

    ACR24 - JAK_TYK2

    A New ACRBest Things I Saw Today in PsADo TNFis and JAKis Prevent Cancer!?Hold or continue JAKi and IL-17 when receiving COVID boosters?JAK-pot! How fast do DMARDs work?JAKi Studies at ACRPoly-treatment of Polymyalgia Rheumatica?RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?RA: One JAK to Rule Them All?SELECT-GCA: Efficacy and Safety of Upadacitinib"SELECT-GCA: Upadacitinib in Giant Cell Arteritis"SELECTing the right patients: upadacitinib in GCASo really, are JAKs Safe?Summary of JAKi StudiesThe Case for JAKi in PMRThe Real Value of JAKi is Beyond RAWhen, What and How Long to Treat GCA & PMRWorried about CV Risk and JAKi? What about the Steroids?

    1 t. 12 min.
  7. ACR24 - LUPUS

    4 DAGE SIDEN

    ACR24 - LUPUS

    A Fibroblast RenaissanceA New ACRA useful urinary biomarker for lupus nephritisANA+ and no Autoimmune Disease? Check the liverCAR-T Therapy and LupusCyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus NephritisEvaluating ANA Patterns and Titers with AINeuropsychiatric Lupus: The Forgotten SymptomsThe 2024 ACR Guidelines for Lupus NephritisVaccine Responses:The DMARD CountsWhat is MCTD? The Great Debate

    46 min.
  8. ACR24 - SPONDYLOARTHRITIS

    4 DAGE SIDEN

    ACR24 - SPONDYLOARTHRITIS

    A New ACRAssessing ASAS Criteria: CLASSIC Study ResultsAssessment and management of axSpAAssessment of axSpACarotid Doppler Ultrasound Screening in Axial SpACycling vs Switching after TNFi Failure in axSpADefining Difficult to Manage axSpADifficult to manage AxSpADISH in SpAGender Differences in AxSpAHighlights in axSpAHot Topics in axSpALong-term Safety Profile of Bimekizumab in axSpA and PsAMachine Learning for Predicting Flares in axSpAPrecision Immunotherapy in Axial SpAPREDICT-SpA: Evaluating the influence of gender on disease assessment toolsTreating SpAWhat is a Positive MRI in Spondyloarthritis?axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure

    1 t. 11 min.
Se alle (908)

Anmeldelser og vurderinger

5
ud af 5
4 vurderinger

Om

Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com

Oplysninger

  • Skaber
    Dr. Cush
  • Aktive år
    2016 - 2024
  • Episoder
    908
  • Vurdering
    Ikke anstødeligt
  • Copyright
    © All rights reserved
  • Websted for serie
    Rheumnow Podcast

Måske vil du også synes om

Log ind for at lytte til episoder med anstødeligt indhold.

Følg med i denne serie

Log ind, eller tilmeld dig for at følge serier, gemme episoder og få de seneste opdateringer.
Vælg et land eller område

Afrika, Mellemøsten og Indien

Asien/Stillehavsområdet

Europa

Latinamerika og Caribien

USA og Canada